Delta 9 Cannabis Inc
TSX:DN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delta 9 Cannabis Inc
Interest Expense
Delta 9 Cannabis Inc
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Delta 9 Cannabis Inc
TSX:DN
|
Interest Expense
CA$5.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Interest Expense
$1.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Interest Expense
CA$41.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Interest Expense
$4.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Interest Expense
CA$10.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Delta 9 Cannabis Inc
Glance View
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 210 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices and Grow Pods. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates an 80,000 square foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The firm also operates a business to business, selling Grow Pods, Cannabis genetics, and providing consulting and licensing services to other cannabis businesses. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company operates 12 cannabis retail stores with an additional eight retail outlet stores in jurisdictions.
See Also
What is Delta 9 Cannabis Inc's Interest Expense?
Interest Expense
5.3m
CAD
Based on the financial report for Mar 31, 2024, Delta 9 Cannabis Inc's Interest Expense amounts to 5.3m CAD.
What is Delta 9 Cannabis Inc's Interest Expense growth rate?
Interest Expense CAGR 5Y
107%
Over the last year, the Interest Expense growth was -7%. The average annual Interest Expense growth rates for Delta 9 Cannabis Inc have been 19% over the past three years , 107% over the past five years .
